Biotech Values

[bellweather1]

I'm not sure Dew-should they be?

I've been inclined to view the fact that over 50% of the stock is controlled by insiders as a plus, because I felt that, on balance, it tends to align the COs interests with those of the shareholders.

I guess I view a monolithic board, which I assume is also dominated by those same insiders, to fall into the same category.

Your thoughts?